Survival Analysis — MCQs
Calculate the maternal mortality ratio (MMR) for the year 2023, given the following data: - Total live births: 4,000 - Women who died: 6 (1 due to a road traffic accident (RTA), 1 due to sepsis, 1 due to obstructed labor, 1 due to eclampsia, 1 due to ectopic pregnancy, and 1 due to a snake bite)
Which measure is best for comparing death rates between two countries?
Which parameter in vitreous humor is most commonly used to estimate the time since death?
The comparison of mortality rates between two countries requires the application of direct standardization. Which of the following parameters makes it necessary to have standardization?
An investigator is studying a new biomarker test to detect breast cancer at early stages. A randomized study is conducted to compare the new test to the current standard of care, mammography, among women over 50 years old. They conclude that breast cancer patients whose cancer was identified by the biomarker lived on average 1.5 years longer than those whose cancers were identified by mammography. If additional independent studies show that there truly was no difference in survival between the two groups, which of the following biases is most likely to have occurred?
In a disease with 100% mortality, what is the relationship between incidence and prevalence?
A drug that does not cure a disease but decreases its symptoms and increases survival leads to increased:
In a statistical analysis, what does the term "standard error" represent?
A multivariate analysis was conducted to examine the relationship between risk of developing blindness and age. The results are shown in the table below. Which of the following is true?
An investigator concluded that the presence or absence of five factors determines the disease condition. Which of the following would be the most appropriate next study to determine if any of these five factors are independent precursors of the disease?
Survival Analysis Indian Medical PG Practice Questions and MCQs
Question 1: Calculate the maternal mortality ratio (MMR) for the year 2023, given the following data: - Total live births: 4,000 - Women who died: 6 (1 due to a road traffic accident (RTA), 1 due to sepsis, 1 due to obstructed labor, 1 due to eclampsia, 1 due to ectopic pregnancy, and 1 due to a snake bite)
- A. 75 per 100,000 live births
- B. 150 per 100,000 live births
- C. 100 per 100,000 live births (Correct Answer)
- D. 125 per 100,000 live births
Explanation: ***Correct: 100 per 100,000 live births*** - The **maternal mortality ratio (MMR)** includes deaths directly or indirectly due to pregnancy, childbirth, or within 42 days of termination of pregnancy, **excluding accidental or incidental causes**. - In this scenario, **4 maternal deaths** are identified: sepsis (direct), obstructed labor (direct), eclampsia (direct), and ectopic pregnancy (direct). - **Excluded deaths**: RTA and snake bite are **incidental/accidental deaths** not related to pregnancy complications. - **Calculation**: MMR = (4 / 4,000) × 100,000 = **100 per 100,000 live births** *Incorrect: 75 per 100,000 live births* - This would incorrectly count only **3 maternal deaths** instead of 4, suggesting underestimation or exclusion of a valid maternal death (e.g., ectopic pregnancy). - Represents a **miscalculation** that underestimates maternal mortality burden. *Incorrect: 150 per 100,000 live births* - This would incorrectly include **6 deaths** (all deaths including RTA and snake bite), failing to exclude incidental causes. - Including **non-maternal accidental deaths** inflates MMR and misrepresents actual maternal health outcomes. *Incorrect: 125 per 100,000 live births* - This would incorrectly count **5 deaths**, suggesting inclusion of one incidental death (either RTA or snake bite). - Fails to properly identify and exclude **both incidental deaths**, leading to an overestimated ratio.
Question 2: Which measure is best for comparing death rates between two countries?
- A. Crude death rate
- B. Age specific death rate
- C. Proportional crude death rate
- D. Age-Standardized mortality rate (Correct Answer)
Explanation: ***Age-Standardized mortality rate*** - This measure accounts for differences in the **age structure** of populations, which is crucial for accurate comparisons between countries. - It adjusts for the fact that older populations naturally have higher death rates, preventing misleading conclusions. *Crude death rate* - This rate does not account for the **age distribution** of a population, making direct comparisons between countries with different age structures problematic. - A country with an older population will naturally have a higher crude death rate, even if its age-specific mortality is lower than a country with a younger population. *Proportional crude death rate* - This refers to the proportion of all deaths due to a specific cause, or within a specific age group, not a rate suitable for comparing overall mortality between two countries. - It does not consider the total population size or age structure, making it inappropriate for direct country-level comparisons of mortality burden. *Age specific death rate* - This measures mortality within specific age groups but does not provide a single summary measure for comparing the overall mortality burden across two entire countries. - While useful for understanding mortality patterns within a country, combining these rates into a comparable metric requires standardization.
Question 3: Which parameter in vitreous humor is most commonly used to estimate the time since death?
- A. K+ level (Correct Answer)
- B. Urea level
- C. Na+ level
- D. Glucose level
Explanation: ***K+ level*** - After death, cell membranes lose their integrity, leading to a steady leakage of **potassium ions** from intracellular to extracellular compartments, including the vitreous humor. - The rate of increase in **vitreous potassium** is relatively predictable and is thus a reliable indicator for estimating the **post-mortem interval (PMI)**. *Urea level* - While urea is present in vitreous humor, its post-mortem changes are not as consistent or well-defined for precise **PMI estimation** compared to potassium. - Urea levels are more influenced by pre-mortem renal function and other physiological factors, making it less reliable. *Na+ level* - **Sodium ion** concentrations in the vitreous humor tend to be relatively stable after death for a longer period compared to potassium. - The changes are not as pronounced or as linearly progressive as potassium, making it a less accurate marker for early **PMI estimation**. *Glucose level* - **Vitreous glucose** levels decrease rapidly after death due to continued glycolysis by residual cells and microorganisms. - While the decrease is significant, it's highly variable and influenced by factors like environmental temperature and bacterial contamination, making it less consistent for precise **PMI estimation**.
Question 4: The comparison of mortality rates between two countries requires the application of direct standardization. Which of the following parameters makes it necessary to have standardization?
- A. Numerators
- B. Denominators
- C. Causes of death
- D. Age distributions (Correct Answer)
Explanation: ***Age distributions*** - **Direct standardization** is crucial when comparing mortality rates between populations with different **age structures**. A population with a larger proportion of older individuals will naturally have a higher crude mortality rate regardless of underlying health. - By standardizing for age, we can remove the confounding effect of age and get a more accurate comparison of **disease burden** or **healthcare effectiveness**. *Numerators* - The numerator in mortality rates typically represents the **number of deaths**, which is a direct count and does not inherently require standardization to be understood. - While the numerator is essential for calculating the rate, its raw value doesn't introduce bias in comparison as much as population characteristics. *Denominators* - The denominator represents the **total population at risk**, which is used in calculating crude mortality rates. - While vital for rate calculation, the denominator itself doesn't directly cause a need for standardization; rather, the **composition** of the denominator (e.g., age groups) is the critical factor. *Causes of death* - While comparing **specific causes of death** can be informative, the "cause of death" itself does not necessitate overall mortality rate standardization. - Standardization focuses on population characteristics (like age) that influence the overall likelihood of death, not the specific etiology.
Question 5: An investigator is studying a new biomarker test to detect breast cancer at early stages. A randomized study is conducted to compare the new test to the current standard of care, mammography, among women over 50 years old. They conclude that breast cancer patients whose cancer was identified by the biomarker lived on average 1.5 years longer than those whose cancers were identified by mammography. If additional independent studies show that there truly was no difference in survival between the two groups, which of the following biases is most likely to have occurred?
- A. Confounding bias
- B. Test insensitivity
- C. Lead time bias (Correct Answer)
- D. Measurement error
Explanation: ***Lead time bias*** - **Lead time bias** occurs when early detection of a disease, such as through a new biomarker, makes it *appear* that survival has increased, even if the actual disease course or prognosis is unchanged. The patient is simply known to have the disease for a longer period. - In this scenario, the biomarker detects cancer **1.5 years earlier** than mammography. This earlier detection artificially inflates the survival time by 1.5 years (from diagnosis to death), even though both groups die at the same chronological age. The apparent survival benefit is simply due to earlier diagnosis, not improved treatment outcomes. - **Key concept**: If a patient would die at age 70 regardless of when cancer is detected, detecting it at age 65 (biomarker) vs age 68.5 (mammography) creates an apparent 3.5-year vs 2-year survival, despite no actual life extension. *Confounding bias* - **Confounding bias** arises when an unmeasured or uncontrolled factor is associated with both the exposure (biomarker use) and the outcome (survival), distorting the perceived relationship. - While confounding can occur in studies, the described phenomenon (earlier detection appearing to extend survival without changing the disease course) is specifically characteristic of lead time bias, not confounding itself. *Test insensitivity* - **Test insensitivity** refers to a screening test's inability to correctly identify individuals who have a particular disease (i.e., a high false-negative rate or low sensitivity). - This bias would lead to *missing* cases, not to an apparent increase in survival for the cases that *are* detected. *Measurement error* - **Measurement error** involves inaccuracies in the data collection process, such as incorrect recording of survival times or faulty test results. - While measurement errors can affect study outcomes, the systematic difference in apparent survival due to earlier diagnosis without actual prognostic improvement is specifically attributed to lead time bias, not general measurement inaccuracies.
Question 6: In a disease with 100% mortality, what is the relationship between incidence and prevalence?
- A. Prevalence is less than incidence (P < I) (Correct Answer)
- B. Prevalence equals incidence (P = I)
- C. There is no relationship between prevalence and incidence
- D. Prevalence is greater than incidence (P > I)
Explanation: ***Prevalence is less than incidence (P < I)*** - In a disease with 100% mortality, all affected individuals will eventually die, meaning their contribution to the **prevalent pool is temporary** or non-existent in the long run. - While new cases (incidence) continue to arise, the rapid removal of cases due to death prevents the buildup of prevalent cases, thus keeping prevalence lower than incidence. *Prevalence equals incidence (P = I)* - This scenario would imply that every new case immediately disappears or that the disease has no duration, which contradicts the concept of **disease progression** and death. - **Prevalence** is influenced by both the incidence rate and the duration of the disease; if duration is effectively zero due to immediate death, the relationship still leans towards prevalence being lower. *There is no relationship between prevalence and incidence* - This statement is incorrect as **incidence and prevalence are fundamentally linked**. Prevalence is a function of incidence and disease duration. - Changes in incidence directly affect **prevalence**, although the extent of this effect is modulated by factors like disease duration, recovery, or mortality. *Prevalence is greater than incidence (P > I)* - Prevalence being greater than incidence typically occurs in **chronic diseases** where individuals live with the condition for a long time, allowing prevalent cases to accumulate. - With **100% mortality**, individuals do not survive long enough to contribute significantly to the prevalent pool, making it impossible for prevalence to exceed incidence in this context.
Question 7: A drug that does not cure a disease but decreases its symptoms and increases survival leads to increased:
- A. Increased incidence
- B. Decreased prevalence
- C. Decreased incidence
- D. Increased prevalence (Correct Answer)
Explanation: ***Increased prevalence*** - A drug that **decreases symptoms** and **increases survival** means people live longer with the disease. - This leads to more existing cases at any given time, thus **increasing prevalence**. *Increased incidence* - **Incidence** refers to the rate of new cases of a disease in a population over a specific period. - A drug that *palliates* symptoms and increases survival does not affect the rate at which new cases develop; therefore, it does not alter incidence. *Decreased prevalence* - **Decreased prevalence** would occur if fewer people had the disease or if people recovered or died more quickly. - Since the drug *increases survival*, it would lead to more people living with the disease for longer, thus increasing, not decreasing, prevalence. *Decreased incidence* - **Decreased incidence** means fewer new cases are occurring. - A palliative drug that extends life does not prevent new cases from arising and therefore does not decrease incidence.
Question 8: In a statistical analysis, what does the term "standard error" represent?
- A. The standard deviation of the sampling distribution of the sample mean (Correct Answer)
- B. The square root of the variance of the sample
- C. The average distance of data points from the mean
- D. The difference between the highest and lowest values in the data set
Explanation: ***The variability of a sample mean*** - The **standard error** quantifies the precision of an estimate of the **population mean**, indicating how much the sample mean would vary if a new sample were drawn from the same population. - It reflects the **sampling variability** of the mean, meaning how much sample means differ from one another across different samples. *The square root of the variance of the sample* - This description typically refers to the **standard deviation** of the sample, which measures the dispersion of individual data points around the sample mean. - While related, the standard deviation focuses on the spread of the data within one sample, whereas the standard error focuses on the spread of sample means across many samples. *The average distance of data points from the mean* - This is a conceptual definition of **standard deviation**, which calculates the typical deviation of observation from their mean. - The standard error, in contrast, specifically addresses the variability of a statistic (like the mean) derived from a sample. *The difference between the highest and lowest values in the data set* - This describes the **range** of a dataset, a simple measure of dispersion that indicates the total spread of values. - The standard error is a more sophisticated measure that accounts for the sample size and variability in estimating a population parameter.
Question 9: A multivariate analysis was conducted to examine the relationship between risk of developing blindness and age. The results are shown in the table below. Which of the following is true?
- A. 60-69 y age group shows statistically significant association with blindness
- B. <50 y age group serves as the reference category
- C. >80 y age group has the strongest association with blindness risk (Correct Answer)
- D. 50-59 y age group has the highest odds ratio for blindness risk
Explanation: ***>80 y age group has the strongest association with blindness risk*** - The odds ratio for the **>80 years** age group is **2.1**, which is the highest among all age groups listed in the table, indicating the strongest association with blindness risk. - A higher odds ratio means a greater likelihood of the outcome (blindness) compared to the reference category. - All age groups shown have **p-values <0.001**, confirming statistical significance. *60-69 y age group shows statistically significant association with blindness* - While the 60-69 y age group has an odds ratio of **1.5** with **p<0.001**, indicating statistical significance, it does not have the strongest association compared to the **>80 y** age group (OR 2.1). - Statistical significance confirms the association is real, but effect size (OR) determines strength of association. *<50 y age group serves as the reference category* - The table shows an **Odds Ratio (OR) of 1.1** for the **<50 y** age group, indicating it is also being compared to a reference (which would have OR = 1.0). - The reference category is not explicitly shown in the table but would typically be an even younger age group or overall population baseline. *50-59 y age group has the highest odds ratio for blindness risk* - The odds ratio for the **50-59 y** age group is **1.2**, which is lower than the **>80 y** age group (OR 2.1), the **70-79 y** age group (OR 1.6), and the **60-69 y** age group (OR 1.5). - This statement is incorrect as the **>80 y** age group clearly has the highest odds ratio for blindness risk.
Question 10: An investigator concluded that the presence or absence of five factors determines the disease condition. Which of the following would be the most appropriate next study to determine if any of these five factors are independent precursors of the disease?
- A. Multiple linear regression analysis
- B. Multiple logistic regression analysis (Correct Answer)
- C. Analysis of variance (ANOVA)
- D. Kruskal-Wallis Analysis of ranks
Explanation: ***Multiple logistic regression analysis*** - This method is appropriate when the **outcome variable** (disease condition) is **dichotomous** (present or absent) - It allows assessment of the **independent effect of each factor** while **controlling for other factors**, helping to identify true independent precursors - Gold standard for modeling **multiple predictors** with a **binary outcome** *Multiple linear regression analysis* - This analysis is used when the **outcome variable is continuous**, not dichotomous like the presence or absence of a disease - Would not be suitable for modeling a binary outcome (disease present/absent) *Analysis of variance (ANOVA)* - ANOVA is primarily used to compare the **means of three or more groups** on a continuous outcome variable - Not designed to assess multiple independent factors influencing a binary outcome - Used for comparing groups, not for modeling predictors of disease *Kruskal-Wallis Analysis of ranks* - This is a **non-parametric test** used for comparing **three or more independent groups** on an ordinal or continuous variable - Similar to ANOVA but for non-normally distributed data - Not suitable for modeling the independent effect of multiple factors on a binary outcome
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free